Branković, M.; Dukić, M.; Gmizić, T.; Popadić, V.; Nikolić, N.; Sekulić, A.; Brajković, M.; Đokić, J.; Mahmutović, E.; Lasica, R.;
et al. New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk. Diagnostics 2024, 14, 229.
https://doi.org/10.3390/diagnostics14020229
AMA Style
Branković M, Dukić M, Gmizić T, Popadić V, Nikolić N, Sekulić A, Brajković M, Đokić J, Mahmutović E, Lasica R,
et al. New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk. Diagnostics. 2024; 14(2):229.
https://doi.org/10.3390/diagnostics14020229
Chicago/Turabian Style
Branković, Marija, Marija Dukić, Tijana Gmizić, Višeslav Popadić, Novica Nikolić, Ana Sekulić, Milica Brajković, Jelena Đokić, Edvin Mahmutović, Ratko Lasica,
and et al. 2024. "New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk" Diagnostics 14, no. 2: 229.
https://doi.org/10.3390/diagnostics14020229
APA Style
Branković, M., Dukić, M., Gmizić, T., Popadić, V., Nikolić, N., Sekulić, A., Brajković, M., Đokić, J., Mahmutović, E., Lasica, R., Vojnović, M., & Milovanović, T.
(2024). New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk. Diagnostics, 14(2), 229.
https://doi.org/10.3390/diagnostics14020229